Stable coronary artery disease
1 paper
- Humans1
Trial sponsors
Company1 trialPhase 298 people
Company1 trialPhase 136 people
1 trialPhase 325 people
Fondazione IRCCS Policlinico San Matteo di Pavia
1 trialPhase 313 people
Peking Union Medical College Hospital
1 trialPhase 1/224 people
Latest
3 in 12 monthsJACC Advances
Incidence of Dementia in Older Adults Hospitalized With Acute Coronary Syndrome: Insights From KP-Brain-Heart Health Study
Cohort study of 154,299 peopleAcute coronary syndrome
The Journal of Nutrition, Health & Aging
Association between accelerated biological aging and major adverse cardiovascular events in patients with stable coronary artery disease
Cohort study of 8,672 peopleCoronary artery disease
AHA Scientific Sessions 2025 Abstract
Multi-omic Characterization of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) Trials Biorepository
Cohort study of 507 peopleBlood and immune system
ADA Scientific Sessions 2025 Abstract
The Significant Reduction in Epicardial Adipose Tissue Thickness after Dapagliflozin Treatment Is Preserved and Even Increased after Four Years—The DAPAHEART Four-Year Follow-up Study
Randomised trial in peopleDapagliflozin
ADA Scientific Sessions 2025 Abstract
A Four-Week Treatment with Dapagliflozin Reduces Insulin-Stimulated Renal Glucose Uptake
Randomised trial in peopleDapagliflozin